tenk.fyi

enGene Holdings Inc.

ENGNNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$117.3M

112.7% YoY

EPS

$2.29

56.8% YoY

Cash

$50.2M

71.0% YoY

FY 2025 · As of 2025-10-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro